Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine

Figure 1

Flow diagram of the presented study. *Patients were withdrawn for one of the following reasons: archival tissue not available (n = 36), no tumor cells in available samples (n = 8), only needle biopsies available (n = 12), tissue samples available from metastasis only (n = 3). Abbreviation: D, docetaxel; DBCG, Danish Breast Cancer Cooperative Group; FFPE, formalin-fixed, paraffin-embedded; GD, gemcitabine plus docetaxel; FISH, fluorescence in situ hybridization; RRM1, ribonucleotide reductase M1 subunit; RRM2B, ribonucleotide reductase M2B subunit.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us